Emerging trends in synthesis, characterization, and mechanism of action of antibody-drug and antibody-nanoparticle conjugates
Abstract Antibody-drug conjugates (ADCs) and antibody-conjugated nanoparticles (ACNPs) are targeted therapies achieved by combining monoclonal antibodies (mAbs) with cytotoxic payloads or nanocarriers. ADCs consist of mAbs conjugated to the cytotoxic payloads via a linker, thus enabling tumor-specif...
Saved in:
| Main Authors: | Tanu Dixit, Annamraju Aswini, Harshal Nikam, Anuradha Vaidya, Selvan Ravindran |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-08-01
|
| Series: | Discover Nano |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s11671-025-04303-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic potential of antibody-drug conjugates possessing bifunctional anti-inflammatory action in the pathogenesis of rheumatoid arthritis
by: Tanu Dixit, et al.
Published: (2024-12-01) -
Production of antibodies and antibody fragments containing non-natural amino acids in Escherichia coli
by: Jacquelyn Blake-Hedges, et al.
Published: (2024-12-01) -
Current issues with antibody-conjugated lipid nanoparticles
by: Aayush
Published: (2025-02-01) -
Antibody drug conjugates
by: Stalin Bala, et al.
Published: (2020-01-01) -
1.4 nm gold nanoparticle-antibody conjugates for in situ gold immunolabelling after transduction into living human cells
by: Groysbeck, Nadja, et al.
Published: (2023-10-01)